Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal lumen osmotic gradient refers to the difference in osmolarity between the contents of the intestinal lumen and the surrounding tissues or blood. This gradient is a key physiological mechanism that drives water movement across the intestinal epithelium, playing a central role in both absorption and secretion of fluids within the gastrointestinal tract. It is established mainly via active electrolyte transport creating local gradients. Disruption or manipulation of this process underlies several clinical conditions like osmotic diarrhea. Key molecular players involved include Sodium channels/pumps, NHEs, SGLT1. It is fundamental for maintaining body fluid balance during digestion and nutrient absorption.
N/A (not a direct drug target; drugs modulate the gradient indirectly)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal Lumen Osmotic Gradient.